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Abstract Age-related loss of skeletal muscle mass and strength are risk factors for sarcopenia, 
osteoporosis, falls, fractures, frailty and mortality. Dietary magnesium (Mg) could play a role in 
prevention of age-related loss of skeletal muscle mass, power and strength directly through 
physiological mechanisms or indirectly through an impact on chronic low-grade inflammation, 
itself a risk factor for loss of skeletal muscle mass and strength.  In a cross-sectional study of 2570 
women aged 18-79 years we examined associations between intakes of Mg, estimated using an 
FFQ, DXA-derived measures of muscle mass (fat free mass as a percentage of body weight 
(FFM%), fat free mass index (FFMI, kg/m
2
)), leg explosive power (LEP) and grip-strength (n=949 
only). We also examined associations between circulating hs-CRP (C-reactive protein) and muscle 
mass and LEP, and explored the potential attenuation of these relationships by Mg.  We compared 
our findings with those of age and protein intake. Endpoints were calculated by quintile of Mg and 
adjusted for relevant confounders.   Significant positive associations were found between a higher 
Mg and indices of skeletal muscle mass and LEP, and also with hs-CRP, after adjustment for 
covariates. Contrasting extreme quintiles of Mg intake showed differences of 2.6% for FFM% (P 
trend <0.001), 0.4 kg/m
2
 for FFMI (P trend=0.005), and 19.6 watts/kg for LEP (P trend<0.001). 
Compared to protein these positive associations were 7 times greater for FFM% and 2.5 times 
greater for LEP. We also found that higher hs-CRP was negatively associated with skeletal muscle 
mass and, in statistical modelling, that a higher dietary Mg attenuated this negative relationship by 
6.5%, with greater attenuation in women aged over 50 years. No association was found between Mg 
and grip strength. Our results suggest that dietary magnesium may aid conservation of age-related 
loss of skeletal muscle mass and power in women of all ages. This article is protected by copyright. All 
rights reserved 
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Introduction 
Age-related loss of skeletal muscle, strength and power are important contributing risk factors to a 
number of conditions including sarcopenia (the loss of muscle mass and strength or physical 
performance), osteoporosis, falls, fractures, weakness, frailty and mortality (1-11). Maintenance of 
skeletal muscle mass and strength are also protective against osteoporosis (5-11). The prevalence of 
sarcopenia ranges from between 1% to 29%, in community dwelling populations over the age of 60 
years, to 14% to 33% in those in long-term care (1, 12-16). The estimated health and social care 
costs of sarcopenia in the United States are $18.5 billion per year with costs of falls and fractures of 
£2.3 billion per year in the UK (and $17 billion in the US) (1, 7, 12-15, 17, 18).  
Given the number and importance of the conditions associated with loss of skeletal muscle 
mass, strength, and function and the predicted increase in age profile of the world wide population 
(25% will be aged over 65 years by 2050) (19), prevention and treatment strategies are clearly 
needed. Nutrition can potentially play a role in prevention but the current evidence relating diet to 
aging of skeletal muscle is largely limited to protein (2).  Dietary magnesium (Mg) is important to 
skeletal muscle due to its direct roles in muscle physiology, and metabolism, and indirect 
interaction with chronic low grade inflammation, which is also a risk factor for loss of skeletal 
muscle mass and strength (2, 16, 20-24). The physiological roles of Mg in skeletal muscle 
metabolism include synthesis of protein, ATP, oxygen uptake, glycogen breakdown, fat oxidation, 
and electrolyte balance (of K, Na and Ca) (25). The importance of Mg to these processes explains 
why 27% of Mg is stored in skeletal muscle, which is the largest store in the body (25).   
Mg may also impact on muscle performance through energy metabolism, transmembrane 
transport and muscle contraction and relaxation, although the evidence in older populations has 
been limited to three studies, finding either a significant relationship between serum Mg 
concentrations or positive effects of Mg supplementation (26-30).   
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The chronic low grade inflammation, associated with ageing, is one mechanism responsible 
for loss of skeletal muscle mass, strength and power, and C-reactive protein (CRP) is an established 
marker of systemic inflammation (22, 23, 31).  Increased circulation of inflammatory cytokines 
CRP (C-reactive protein), IL-6 and TNF-α have been associated with lower indices of skeletal 
muscle mass or physical performance, grip strength or disability, in a number of cross-sectional and 
longitudinal studies (20-24). 
Dietary Mg could reduce the circulation of inflammatory cytokines and recent systematic 
review evidence found that a higher dietary intake of Mg was, in the main, inversely related to 
circulating CRP concentrations (32, 33). Previous intervention studies with Mg supplements found 
mixed effects on circulating hs-CRP but do not reflect the effects of diet, as supplements consist of 
single compounds with variable bioavailability (32, 34-36). 
Despite the biological plausibility that greater intakes of dietary Mg would be associated 
with improved skeletal muscle mass, grip strength and power, to our knowledge there has only been 
one previous cross-sectional study which found a positive relationship between dietary Mg and 
appendicular lean mass but not grip strength (37). Furthermore, no previous population study has 
examined the possible mediating effects of dietary Mg on inflammation in addition to its association 
with skeletal muscle mass, strength and power. 
This study was designed to investigate the hypothesis that dietary Mg would be associated 
with better indices of skeletal muscle mass, strength and power and would also attenuate a potential 
negative relationship between circulating hs-CRP and skeletal muscle mass and power. Using 
detailed data available for a large healthy adult population of female twins we aimed firstly to 
understand the relationship between dietary Mg and indices of skeletal muscle mass, strength and 
power, secondly to investigate the relationship between circulating hs-CRP and muscle mass, 
thirdly to understand the relationship between dietary Mg and circulating hs-CRP, and finally, to 
determine whether dietary Mg would attenuate the relationship between circulating hs-CRP and 
muscle mass or explosive leg power.  
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Methods 
The women included in this study were from the TwinsUK registry which is an ongoing study of 
healthy adult twin volunteers who underwent clinical examinations for a number of characteristics 
associated with aging and is representative of adult singleton populations in the United Kingdom 
(38, 39). The women for this study were in two groups, group 1 selected as those participants who 
had completed a food frequency questionnaire (FFQ) and attended for dual-energy X-ray 
absorptiometry (DXA) measurements between 1996 and 2000 (referred to as the ‘fat free mass 
group’ in this manuscript) included 2570 women. Within this ‘fat free mass’ group there were 1914 
individuals with measures of leg explosive power and 1658 individuals who also had measures of 
high sensitivity C-reactive protein (hs-CRP). Within the fat free mass group 1189 individuals had 
both measurements of leg explosive power and hs-CRP. The ‘grip strength group’ consisted of 
women who had completed an FFQ and had body composition and grip strength measurements 
measured between 2005 and 2008 and was aged 34 to 83 years at the time of the measurements. 
There were 512 individuals with full data available in both the muscle mass and grip strength 
groups.  
Zygosity was ascertained by questionnaire and confirmed by multiplex-DNA fingerprinting 
(PE Applied Biosystems) (40). Information on lifestyle, medication use, menopausal status, and 
demographic variables were obtained using a standardised nurse-administered questionnaire. 
Physical activity was classified as heavy, moderate or inactive during work, home and leisure time 
using a questionnaire that has been strongly correlated with a more in depth assessment of physical 
activity in this cohort (41).  
Ethical approval was obtained from the St. Thomas’s Hospital Research Ethics Committee 
and informed consent acquired from all participants. 
Measurement of dietary intake. Assessment of Mg, protein and energy intake were measured using 
a 131 item validated food frequency questionnaire (FFQ) with nutrients calculated using the UK 
Nutrient Database (42, 43). Individuals were excluded if answers to > 10 food items were left blank 
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or the ratio of estimated total energy intake to the estimated basal metabolic rate fell 2 SDs outside 
the mean ratio. The dietary intake data was estimated for the appropriate time period for the ‘fat free 
mass’ and ‘grip strength’ groups. To estimate potential dietary mis-reporting the ratio of reported 
energy intake (EI) to estimated energy expenditure (EER), the EI:EER ratio, was calculated and was 
included as a covariate for adjustment in the statistical analyses (44). 
Assessment of body composition. Weight and height were measured to the nearest 0.5 cm and 0.1 
kg, respectively.  BMI was calculated as weight in kilograms (kg) divided by height in meters 
squared (m
2
). Fat free mass (FFM) was measured by dual-X-ray absorptiometry (DXA) (Hologic 
QDR-2000 DXA scanner, Hologic Inc., Waltham, MA, USA) in kg. Fat free mass (FFM%) as a 
percentage of body weight was calculated as (FFM kg/total body weight) *100. The fat free mass 
index (FFMI) in kg/m
2
 was calculated as (FFM kg/height in square meters) as this eliminates the 
proportional increase in fat free mass that occurs with increasing height (45).  
Measurement of grip strength and leg explosive power. Isometric grip strength was assessed using a 
Jamar hand grip dynamometer (Sammons, Preston, UK) on the dominant arm with reproducibility 
assessed by repeated measurement on 24 individuals (CV of 11.4%) (46).  
Leg explosive power (LEP) was used to measure physical fitness using the Nottingham power rig 
which measures the force and velocity of muscle contraction principally from the quadriceps (47).  
It is has been validated and is highly reliable (reliability coefficient 0.97, coefficient of variation 
9.4%, over one week period in adults) (47). Values for LEP were divided by individual body weight 
and multiplied by the mean body weight of the population to obtain body-size adjusted values in 
watts/kg. 
Measurement of C-reactive protein. Circulating high sensitivity C-reactive protein (hs-CRP) was 
measured by a highly sensitive automated microparticle capture enzyme immunoassay, standardised 
on the World Health Organisation International Reference Standard for CRP immunoassay, as 
previously described (48). 
Statistical analyses 
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First set of analyses: We examined the relationship of dietary Mg, skeletal muscle mass and 
strength and hs-CRP in a three step process using regression techniques. Also, as data from 
members of twin pairs could not be treated as independent, we controlled for familial aggregation 
by using the robust regression cluster option in the Stata software. Firstly we estimated the 
independent association of dietary Mg with each of the outcome variables using multivariable 
regression adjusted analyses. Dietary Mg was divided into quintiles and statistical models run to 
calculate the unadjusted (model 1) and adjusted (model 2) values for FFM%, FFMI, grip strength, 
LEP and Hs-CRP. To account for the known associations between fat free mass, grip strength, LEP 
and Hs-CRP with age (years), physical activity (active, moderately active, inactive), smoking habit 
(never, former, current), protein intake (in quintiles) and potential mis-reporting (EI:EER) all 
models included these variables (2, 49, 50). Additionally as fat free mass increases with greater 
body size analyses for FFMI were also adjusted for total fat mass (kg) (45). For grip strength and 
LEP the models were also adjusted for menopausal status (pre-menopausal/ post-menopausal), the 
use of HRT (yes/no) and height (m) (51). As vitamin D has been related to muscle mass and 
function so we performed an additional model that included dietary vitamin D (52). The interaction 
between age and magnesium intake on grip strength was also tested. For hs-CRP model 2 also 
included anti-inflammatory (yes/no) and HRT medication (yes/no) (51). As the hs-CRP distribution 
was skewed natural long-transformed values were used in all models. P-trend values were 
calculated with regression using ANCOVA with the quintile categories used as a continuous 
variable. The values in Table 2 show the unadjusted means (model 1) and adjusted means and 
standard errors (model 2). In figure 2 the adjusted means for FFM% and FFMI are shown and in 
Figure 3 those for leg explosive power. 
Second set of analyses: to compare the scale of our findings with dietary Mg with other 
factors known to influence indices of skeletal muscle mass we compared the associations with, of 
Mg and skeletal muscle mass (FFM% and FFMI) and LEP with those of age, and dietary protein. 
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The beta coefficients from the fully-adjusted regression model (model 2) were compared by 
including them in the equation:  
(ß coefficient dietary Mg/ ß coefficient age or protein)*100. 
For these analyses dietary Mg and protein were divided into quintiles, age into 10-year age groups 
and all other covariates as described above. 
Third set of analyses - attenuation models. As we found an associations between dietary Mg and hs-
CRP and with hs-CRP and skeletal muscle, to evaluate the potential attenuation of the relationship 
between hs-CRP and skeletal muscle by Mg we added Mg (in quintiles) to the fully adjusted hs-
CRP regression model to assess the percent change of the beta coefficient for FFM% or FFMI.  
Attenuation as a percentage was calculated as ((β2- β1)/ β1)*100. The significance of the 
attenuation was tested by dividing the attenuation coefficient by its standard error term to calculate 
a z score for the attenuation (53). A z score greater than 1.96 was considered significant at the 0.05 
level.   
In order to understand the whether the associations were different in older and younger 
women we repeated all analyses in the whole cohort stratified by age groups (<50 years or ≥50 
years).   
The contribution of different food groups to Mg intake was calculated. 
All analyses were performed with Stata statistical software version 11.0 (Stata Corp, College 
Station, TX) and included the robust cluster regression option in STATA. 
Results 
The group of women in which grip strength was measured was older and had a higher BMI than the 
‘muscle mass group’, as expected given the dates of measurement, Table 1. This ‘grip strength 
group’ had fewer women in the active and moderately active physical activity groups than the ‘fat 
free mass group’ (78.1% versus 60.5%).  
Relationships between dietary Mg and indices of skeletal mass, strength and leg explosive power. 
Significant positive associations were found between dietary Mg and both FFM% (P trend <0.001) 
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and FFMI (P trend=0.005) after adjustment for covariates, with between extreme quintile 
differences of 2.6% for FFM% and 0.4 kg/m
2
 for FFMI in the fat free mass group, Table 2. When 
stratified by age these trends were significant in both age groups with between quintile differences 
of 2.3% for FFM% (P=0.001) in those aged less than 50 years compared with 2.82% (P<0.001), in 
those over 50, see Figure 1. For FFMI there were stronger associations with dietary Mg in those 
aged less than 50 years compared with those aged 50 years or more; differences of 0.47 kg/m
2
 
(P=0.009) and 0.31 kg/m
2
 (P=0.113), respectively, Figure 1.We found a strong positive association 
between LEP and dietary Mg both before and after adjustment for covariates with a difference of 
19.6 watts/kg between quintile 1 and 5 (P trend <0.001) in the fully adjusted model, a 24.1% 
difference, Table 2. There was no association between grip strength and Mg intake in either the 
adjusted or unadjusted models in the grip strength group, Table 2. We also found no interaction 
between age and magnesium intake and grip strength (P=0.499). In analyses stratified by age these 
associations remained significant with between quintile differences of 14.2 watts/kg (P trend 
=0.001) and 14.9 watts/kg (P trend = 0.002) representing percentage differences of 15.1% and 
21.2% in women under and over 50 years of age, respectively, see Figure 2. The addition of dietary 
vitamin D to the fully adjusted models did not alter the findings (data not shown). 
Comparison with other known factors related to skeletal muscle mass. In comparison with other 
known factors related to skeletal muscle mass, in the multivariate adjusted regression model, the 
difference of FFM% per 10 years of age (ß coefficient) was -0.41% per 10 years (P<0.001 – CI -
0.253 to -0.581), the association with protein as a percentage of energy was - was (ß coefficient)  
0.08% per quintile (P=0.072 – CI -0.178 to 0.008) and the association of dietary Mg was 0.24% per 
quintile P<0.001 – CI 0.383 to 0.888). This indicates that the association between dietary Mg and 
FFM% was about 60% of that of age ((0.24%/0.41%)*100=58.5 %) (after adjustment for all 
covariates). Compared with the association with protein the association with Mg was three times 
greater than protein ((0.24%/0.08%) = 3). For FFMI the equivalent figures were 0.19kg/m
2
 
(P<0.001 – CI -0.012 to 0.027) for age and 0.094kg/m2 (P=0.05 – CI 0.029 to 0.158) for Mg, 
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indicating that the association was around half that of age (((0.094/0.19)*100) = 49.5%). Similarly 
the association with dietary protein was 0.014 kg/m
2
 (P=0.552 – CI -0.032 to 0.060) and compared 
with Mg was (0.094/0.014=6.7), indicating that the association with Mg was almost 7 times greater 
than with protein. 
In analyses repeated with LEP the association with Mg compared with that of age was ((4.97 
watts/kg 3.31 watts/kg)*100 = 150%) i.e. one and a half times that of age and for protein was ((4.98 
watts/kg/1.96 watts/kg)*100 = 254%) i.e. 2.5 times that of protein. 
Relationships between dietary Mg and hs-CRP. There was a inverse association between dietary Mg 
and hs-CRP in the adjusted model with a lower hs-CRP in the highest quintile of Mg intake (Q5) 
compared with Q1; an inter quintile difference of 0.59 mg/L (P trend = 0.011), equivalent to 28.9% 
of Q1, Table 2. 
Relationships between indices of skeletal muscle and hs-CRP and the attenuation analyses. The 
unadjusted association between indices of muscle mass and CRP (per quintile of CRP) was -1.4 % 
(P trend = 0.001) for FFM% and 0.23 kg/m
2
 (P trend = 0.001) for FFMI. When stratified by age 
group the figures for FFM% were -1.0% (P trend <0.001) in those aged less than 50 years and -
1.4% (P trend <0.001) in those over 50 years of age. For FFMI the equivalent figures were 0.19 
kg/m
2
 (P trend <0.001) in those aged less than 50 years and -0.28 kg/m
2
 (P trend <0.001) in those 
over 50 years of age. 
In multivariable regression, with the covariates included in model 1, the association between 
FFM% and hs-CRP was -0.309% per quintile of hs-CRP (P trend =0.001). Inclusion of Mg 
additionally in the model (model 2) reduced this association of FFM% and hs-CRP to -0.289% per 
quintile of hs-CRP (P trend =0.001), Figure 3. When calculated as the percentage difference 
between model 1 and model 2 this calculated attenuation was 6.5% i.e. the association between hs-
CRP and FFM% was attenuated by 6.5% when Mg was included in statistical model 2 (z score for 
attenuation = 2.7, p<0.05). After stratification for age, into those who were aged either more or less 
than 50 years, the equivalent coefficients were -0.285% (P=0.017) and 0.272% (P=0.038), 
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respectively (with Mg included in model 2), Figure 3. This represented attenuation by inclusion of 
Mg in the model of 4.6% in those aged less than 50 years (z score for attenuation = 1.7, p>0.05) 
compared with 5.8% in those aged 50 years and over (z score for attenuation = 1.8, p>0.05). 
Repeating the statistical analyses with models 1 and 2 but including FFMI as the main 
outcome in the models, the association between hs-CRP in model 1 was -0.00253 kg/m
2
 (P=0.83) 
and inclusion of Mg to model 2 reduced the association to -0.00015 kg/m
2
 (P=0.99). The calculated 
percentage attenuation was for the whole age group was 0.06% and for those aged less than 50 
years was 35%, and was 89% in those aged over 50 years. However, none of these associations 
were significant (P>0.5). 
In our analyses with LEP and hs-CRP no association was found in the fully adjusted model - 
ß 0.024 watts per quintile of hs-CRP (P trend = 0.977), data not shown. 
Contribution of foods to intake. The main foods that contributed to 81.1% of Mg intake in this 
population were fruit and vegetables (33.0 %), cereal foods (20.3%), dairy foods (14.8 %), potatoes 
(7.0 %) and meats and products (6.0%). Around a quarter of women (27.2%) had intakes of Mg 
below the UK Reference Nutrient Intake of 270 mg/d. 
Discussion 
To our knowledge this is the first study to assess comprehensively the associations between dietary 
Mg intake, skeletal muscle mass, power and strength, and an inflammatory biomarker, in the same 
well-characterised dataset. In our study we found that a higher dietary Mg intake was significantly 
associated in a beneficial direction with indices of skeletal muscle mass (FFM% and FFMI) and leg 
explosive power, and also with circulating CRP concentrations. These associations remained after 
adjustment for covariates including protein intake, age, physical activity and smoking habit. We 
also found that higher hs-CRP was negatively associated with lower indices of skeletal muscle mass 
and, in statistical modelling, that dietary Mg attenuated this negative relationship. Although our 
findings applied to women of all ages we found that the associations of dietary Mg with indices of 
skeletal muscle, and the attenuation by Mg, of the association between CRP and muscle, were 
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greater in women aged over 50 years. We found no associations between dietary Mg and grip 
strength or between LEP and hs-CRP. 
In line with our positive finding of an association of dietary Mg with FFM% and FFMI the 
only previous study (in older men and women) found a positive relationship between Mg intake and 
appendicular lean mass, at baseline, of 0.07 kg per quartile of Mg intake (P=0.02) (37). This 
compares with the difference of 0.091kg/m
2
 (P=0.05) of FFMI per quintile of Mg found in our 
cohort, although we adjusted for more covariates than those authors did. Our finding represents an 
interquartile absolute difference of 0.4kg/m
2
 of FFMI which, expressed as a percentage of the 
lowest quintile, is equivalent to difference of 4.3% for FFMI. We also found a 24.2% greater LEP 
with the highest intake of Mg compared to the lowest. We found this difference with an intake of 
around 250 mg of Mg per day. This amount of Mg, administered as Mg oxide, in a recent 
intervention study of  middle-aged overweight women, found an increase in percentage lean body 
mass (1.3%, P=0.03) over 8 weeks (29). In comparison our study found a cross-sectional difference 
of 2.6% of FFM% between extreme quintiles of Mg intake. To our knowledge our study is the first 
to investigate the association between dietary Mg and LEP (although a previous study investigated 
LEP and circulating Mg) (28). Moreover, our results with dietary Mg and indices of skeletal muscle 
mass and LEP were continuous across the whole range of distribution of intake, even though 27% 
of our cohort ate less than the UK reference nutrient intake. Mean intakes of Mg in our study were 
higher than in a recent UK population study, although we used an FFQ which produces higher 
intakes of certain nutrients than diary methods (54). Maintenance of circulating Mg is tightly 
regulated with concentrations of less than 0.7 mmol/L considered deficient and of 1.0 mmol/L 
considered to be in excess. Mg absorption varies according to intakes, and providing renal function 
is not compromised, it is unlikely that higher dietary intakes would have a detrimental effect but 
further research is needed (44). 
To our knowledge only one other study has investigated the association between hs-CRP 
and leg power, finding a significant positive association with lower knee extensor power (55). The 
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lack of association that we found with dietary Mg and grip strength is in line with the only other 
previous study relating dietary Mg to knee muscle strength, although one study found a positive 
association between grip strength and circulating Mg (28, 37). 
Similar to other previous studies we also found an association between a higher intake of 
Mg and circulating hs-CRP with an interquartile difference of 28.9%, Table 1 (20-22).  
The calculated attenuation of dietary Mg on the negative relationship between hs-CRP and 
indices of muscle mass, of 6.5% for FFM%, demonstrates a significant effect of dietary Mg. This 
was greater in older than in younger women, indicating that dietary Mg may play a greater role in 
the conservation of the skeletal muscle in older women, through attenuation of circulating 
cytokines. Furthermore our findings are plausible, given the integral role Mg plays in skeletal 
muscle physiology, metabolism, composition and the previous research relating dietary and 
supplemental Mg to CRP (26-30, 34). Overall our results support the potential for dietary Mg to 
play a role in the conservation of skeletal muscle mass and power (26). The major dietary sources of 
Mg include green leafy vegetables and unprocessed grains and the difference between extreme 
quintiles of 256 mg found in our cohort could be supplied by a diet that included rich sources of Mg 
(for instance, almonds, spinach, bananas, fortified breakfast cereals and wholemeal bread), as well 
as by following the UK and USA dietary guidelines that include 5-portions of fruits and vegetables 
per day.  
To place our study findings in context we compared the relationship with fat free mass and 
LEP and dietary Mg intake with those of either ten years of age (one decade) or of quintiles of 
percentage dietary protein intake, known factors that relate to skeletal muscle mass. The association 
per quintile of dietary Mg was between 3 and 7 times that of per quintile of protein, and between 
50% and 60% of the equivalent of one decade of age. For LEP the associations were 2.5 times that 
of protein and 1.5 times that of age. This provides further support for the important potential for 
dietary Mg to play a role in conservation of skeletal muscle mass and power. Moreover leg 
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explosive power declines with age earlier, and more dramatically, than strength and has a greater 
impact on functional impairments and influences mobility more than leg strength (47, 56-58). 
Sarcopenia is a particular issue for older adults, but muscle mass is lost from midlife 
onwards.  Although the loss of strength as well as skeletal muscle mass does not entirely explain the 
onset of sarcopenia both remain important (59). Although we showed greater attenuation effects in 
those over 50 years for FFM% our results suggest that dietary Mg may also have benefits in mid-
life, contributing to the preservation of both muscle mass and power, potentially attenuating the 
later development of sarcopenia. Thus our findings have relevance to the timing of future 
intervention studies. Moreover, unlike protein supplementation, Mg also holds promise for older 
populations.   
The strengths of our study include the large population size and wide age distribution with 
DXA measurements of body composition and measures of LEP, grip strength and circulating hs-
CRP and dietary intakes. One benefit of measuring dietary intake is that the results from this study 
are directly applicable for dietary advice. Our FFQ has also been validated using urinary excretion 
of potassium, and dietary potassium and Mg are highly correlated (42). We also measured total fat 
free mass which is highly correlated to appendicular lean mass, and used FFMI which takes into 
account differences in skeletal muscle with height (2). 
One limitation of our study is that we were unable to investigate the association between hs-
CRP and muscle strength due to the lack of availability of data but we were able to measure 
associations with LEP. Our study was also only in women and we do not know if the results would 
be the same in men, although low-grade inflammation is also a risk factor for loss of skeletal muscle 
mass and strength in men. Although we adjusted for all known confounders in our analyses we 
cannot discount the fact that dietary Mg may be a reflection of an overall healthy eating pattern. 
Moreover, as this was a cross-sectional study we cannot infer causation. Also, our statistical 
findings of the attenuation of dietary Mg on the association between indices of skeletal muscle mass 
and hs-CRP would need confirmation in an intervention trial.  
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In summary we found significant positive associations of dietary Mg with indices of skeletal 
muscle mass and leg explosive power. For skeletal muscle mass the scale of the associations with 
Mg were 2.6% for FFM% and 4.3% for FFMI which were three to seven times greater than the 
association that we found with protein. For LEP the scale of the association was 24.2 % and was 2.5 
times greater than with protein. Furthermore dietary Mg was related to circulating CRP and, in 
statistical analyses, attenuated the negative association between hs-CRP and percentage of muscle 
mass by 6.5%, with the results being greater in older than in younger women. Our results suggest 
that dietary Mg may aid conservation of age-related loss of skeletal muscle mass and power, in 
women of all ages, and so requires further investigation. 
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Table 1: Characteristics and dietary intakes of females aged 18-79 years 
Characteristics  Fat free mass group 
(n=2570) 
Grip strength group 
(n=949) 
Age (years) 48.3 (12.7) 59.1 (9.3) 
BMI (kg/m
2
) 24.9 (4.1) 26.5 (4.7) 
Weight (kg) 65.6 (11.2) 69.2 (12.5) 
Height (m) 162 (6.1) 162 (5.9) 
Fat mass (kg) 22.7 (7.9) - 
Fat free mass (%) 33.9 (7.2) - 
Fat free mass index (kg/m
2
) 15.0 (1.7) - 
Hand grip strength (kg) - 28.8 (5.9) 
Leg explosive power
 a
 (watts) 89.8 (36.8) - 
Leg explosive power
 a
 (watts/kg) 90.9 (36.5) - 
hs-CRP
 b
 (mg/L) 2.49 (2.3) - 
Energy intake (kcal/d) 1979 (524) 1911 (635) 
Magnesium (mg/d) 344 (92.3) 350 (110) 
Protein (% energy) 16.6 (2.6) 17.7 (2.8) 
Under-reporting (EI:EER, %) 87.4 (24.6) 89.2 (33.7) 
Physical activity (active, %) 24.2% (622) 26.0% (247) 
                           (moderately active, %) 53.9% (1385) 34.5% (327) 
                           (inactive, %) 21.9% (563) 39.5% (375) 
Smoking status (current, %) 18.2% (468) 9.7% (92) 
Anti-inflammatory medication (yes, %) 6.2% (102)
 2
 - 
Menopausal status (post-menopausal, %) - 89.8% (852) 
Hormone replacement therapy (yes, %) 6.3% (105)
 2
 9.5% (90) 
Values are mean (SD) or % (n=) 
EI:EER - ratio of reported energy intake to estimated energy requirements, expressed as a 
percentage  
Values for a subset of 
a
1914 and 
b
1658 participants in the fat free mass group 
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Table 2: Percentage fat free mass, fat free mass index, grip strength and high sensitivity C-
reactive protein by quintile of magnesium intake in 2570 females aged 18-79 years
 
 Model  Q1 
(n=514) 
Q2 
(n=514) 
Q3 
(n=514) 
Q4 
(n=514) 
Q5 
(n=514) 
P-
trend 
Q5-
Q1 
% of 
Q1 
Magnesium 
(mg/d) 
 225 (31.6) 291 (14.0) 337 (12.6) 384 (15.9) 481 (60.8) - - - 
Fat free 
mass (%) 
1 61.1 
(0.31) 
60.7 
(0.30) 
61.2 
(0.31) 
61.3 
(0.31) 
61.3 
(0.32) 
0.335 0.2 0.3 
2 60.0 
(0.34) 
60.3 
(0.27) 
61.1 
(0.24) 
61.5 
(0.25) 
62.6 
(0.34) 
<0.001 2.6 4.3 
Fat free 
mass index 
(kg/m
2
) 
1 14.8 
(0.09) 
15.0 
(0.08) 
15.0 
(0.08) 
15.1 
(0.08) 
15.2 
(0.08) 
0.008 0.4 2.7 
2 14.8 
(0.09) 
15.0 
(0.07) 
15.1 
(0.06) 
15.1 
(0.07) 
15.2 
(0.08) 
0.005 0.4 2.7 
Grip 
strength 
(kg)
a
 
1 28.5 
(0.44) 
28.9 
(0.49) 
28.5 
(0.44) 
28.7 
(0.47) 
29.2 
(0.44) 
0.348 0.7 2.5 
2 28.7 
(0.41) 
28.8 
(0.44) 
28.4 
(0.37) 
29.1 
(0.39) 
28.7 
(0.49) 
0.847 0 0.0 
Leg 
explosive 
power 
(watts/kg)
b
 
1 88.9 
(1.97) 
88.9 
(1.86) 
89.2 
(1.92) 
94.1 
(2.03) 
93.1 
(2.12) 
0.032 4.2 4.7 
2 81.1 
(2.30) 
86.6 
(1.85) 
89.2 
(1.76) 
96.8 
(1.94) 
100.7 
(2.47) 
<0.001 19.6 24.2 
Hs-CRP 
(mg/L)
c
 
1 1.73 
(1.54-
1.94) 
1.54 
(1.38-
1.72) 
1.55 
(1.38-
1.73) 
1.66 
(1.48-
1.87) 
1.51 
(1.36-
1.69) 
0.295 -
0.22 
-
12.7 
2 1.94 
(1.69-
2.23) 
1.57 
(1.41-
1.75) 
1.58 
(1.42-
1.75) 
1.60 
(1.44-
1.79) 
1.35 
(1.19-
1.53) 
0.011 -
0.56 
-
28.9 
Values for magnesium are mean (SD) and all other values are mean (SE). P-trend values were 
calculated using ANCOVA. Q5-Q1 is the value in Q5 minus the value in Q1. % of Q1 is the
 
difference between Q5 and Q1 calculated as the percentage of the value in Q1. 
Model 1 was unadjusted. Model 2 was adjusted for age, physical activity, smoking status, energy 
intake, protein intake and underreporting and fat free mass index was additionally adjusted for fat 
mass.   
 
a 
Analysis for the grip strength group (n=949). Model 1 was unadjusted. Model 2 was adjusted for 
age, physical activity, smoking status, energy intake, protein intake, underreporting, menopausal 
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status, use of HRT and height.  Participant numbers were Q1=192; Q2=190; Q3=191; Q4=190; 
Q5=186 and intakes of magnesium (mean ± SD) were as follows Q1=219 ± 32.9; Q2= 290 ± 14.6; 
Q3= 339 ± 14.7; Q4= 394 ± 17.7; Q5= 516 ± 97.2
  
 
b 
Subset analysis for 1914 participants in the fat free mass group.  Model 1 was unadjusted. Model 2 
was adjusted for age, physical activity, smoking status, energy intake, protein intake, 
underreporting, menopausal status, use of HRT and height.  Participant numbers were Q1=383; 
Q2=383; Q3=383; Q4=383; Q5=382 and intakes of magnesium (mean ± SD) were as follows 
Q1=224 ± 32.4; Q2= 291 ± 13.8; Q3= 336 ± 12.9; Q4= 384 ± 15.4; Q5= 480 ± 59.3 
 
c 
Subset analysis for 1658 participants in the fat free mass group. Values are geometric mean (95% 
CI). Model 1 was unadjusted. Model 2 was adjusted for age, BMI, physical activity, smoking status, 
energy intake, protein intake, underreporting, and use of anti-inflammatory medication and HRT.  
P-trend values were based on log concentrations using ANCOVA.  Participant numbers were 
Q1=332; Q2=332; Q3=331; Q4=332; Q5=331 and intakes of magnesium (mean ± SD) were as 
follows Q1=232 ± 30.1; Q2= 293 ± 12.5; Q3= 336 ± 12.8; Q4= 384 ± 15.7; Q5= 480 ± 60.7 
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